Cancer Research and Treatment 2021 10.4143/crt.2021.151

Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue

Noh¹, JM; Kim, YJ; Lee, HY; Choi, CH; Ahn, WG; Lee, TS; Pyo, HR; Park, JH; Park, DH; Park, WY

European Radiology 2021 10.1007/s00330-021-08342-6

Pragmatic role of noncontrast magnetic resonance lymphangiography in postoperative chylothorax or cervical chylous leakage as a diagnostic and preprocedural planning tool

Hyun¹, DH; Lee, HY; Cho, JH; Kim, HK; Choi, YS; Kim, JG; Zo, JI; Shim, YM

Cancer Research and Treatment 2021 10.4143/crt.2021.822

The Impact of EGFR Tyrosine Kinase Inhibitor on the Natural Course of Concurrent Subsolid Nodules in Patients with Non-Small Cell Lung Cancer

Kang¹, NE; Kim, KH; Jeong, BH; Lee, KJ; Kim, HJ; Kwon, OJ; Ahn, MJ; Cho, JH; Lee, HY; Um, SW

Journal of Thoracic Oncology 2021 10.1016/j.jtho.2021.09.007

Lung Cancer in Korea

Park¹, SH; Choi, CM; Hwnag, SS; Choi, YL; Kim, HY; Kim, YC; Kim, YT; Lee, HY; Song, SY; Ahn, MJ

Thoracic Cancer 2021 10.1111/1759-7714.14297

The rarest of rare cases within the one thousand faces of atypical carcinoid: Pseudomesotheliomatous manifestation in a pregnant woman

Kim¹, HR; Lee, HY; Lee, SH; Lee, IS; Choi, JY; Shim, YM

Translational Lung Cancer Research 2021 10.21037/tlcr-21-677

Prognosis of pulmonary lymphangitic carcinomatosis in patients with non-small cell lung cancer

Im¹, YJ; Lee, HW; Lee, HY; Baek, SY; Jeong, BH; Lee, KJ; Kim, HJ; Kwon, OJ; Han, JH; Lee, KS; Ahn, MJ; Kim, JG; Um, SW

Radiology 2022 10.1148/radiol.213084

Time to Scrutinize and Revise the Fine Print of Lung Cancer Screening Using Low-Dose CT: Seeking Greater Confidence in Cancer Detectability

Lee¹, HY

Communications Biology 2021 10.1038/s42003-021-02814-7

Radiomics-guided deep neural networks stratify lung adenocarcinoma prognosis from CT scans

Cho¹, HH; Lee, HY; Kim, EJ; Lee, GW; Kim, JH; Kwon, JM; Park, HJ

Journal of Thoracic Oncology 2021 10.1016/j.jtho.2021.06.001

A Wake-Up Call for Immune Checkpoint Inhibitor-Related Pneumonitis

Lee¹, HY

KOREAN J RADIOL 2021 10.3348/kjr.2020.0955

Imaging Assessment of Visceral Pleural Surface Invasion by Lung Cancer: Comparison of CT and Contrast-Enhanced Radial T1-Weighted Gradient Echo 3-Tesla MRI

Zhang¹, Y; Kwon, W; Lee, HY; Ko, SM; Kim, SH; Lee, WY; Yong, SJ; Jung, SH; Byun, CS; Lee, J; Yang, H; Han, J; Ackman, JB

CANCER IMAGING 2021 10.1186/s40644-021-00400-y

Are radiomics features universally applicable to different organs?

Lee¹, SH; Cho, HH; Kwon, J; Lee, HY; Park, H

RADIOLOGY 2021 10.1148/radiol.2021203427

Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society

Johkoh¹, T; Lee, KS; Nishino, M; Travis, WD; Ryu, JH; Lee, HY; Ryerson, CJ; Franquet, T; Bankier, AA; Brown, KK; Goo, JM; Kauczor, HU; Lynch, DA; Nicholson, AG; Richeldi, L; Schaefer-Prokop, CM; Verschakelen, J; Raoof, S; Rubin, GD; Powell, C; Inoue, Y; Hatabu, H

EUR RADIOL 2021 10.1007/s00330-020-07648-1

Hyperattenuating adrenal lesions in lung cancer: biphasic CT with unenhanced and 1-min enhanced images reliably predicts benign lesions

Lee¹, HY; Oh, YL; Park, SY

THORAC CANCER 2020 10.1111/1759-7714.13701

Clinical T category for lung cancer staging A pragmatic approach for real-world practice

Choi¹, Y; Kim, SH; Kim, KH; Choi, Y; Park, SG; Sohn, I; Kim, HS; Um, SW; Lee, HY

THORAC CANCER 2020 10.1111/1759-7714.13632

Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung Incidence, prognostic impact, and prediction based on clinicoradiologic factors

Lee¹, MA; Kang, J; Lee, HY; Kim, W; Shon, I; Hwang, NY; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM

THORAC CANCER 2020 10.1111/1759-7714.13580

Prediction of tumor doubling time of lung adenocarcinoma using radiomic margin characteristics

Yoon¹, HJ; Park, H; Lee, HY; Sohn, I; Ahn, J; Lee, SH

THORAC CANCER 2020 10.1111/1759-7714.13568

Parallel comparison and combining effect of radiomic and emerging genomic data for prognostic stratification ofnon-small celllung carcinoma patients

Kim¹, KH; Kim, J; Park, H; Kim, H; Lee, SH; Sohn, I; Lee, HY; Park, WY

EUR RADIOL 2020 10.1007/s00330-019-06581-2

Marginal radiomics features as imaging biomarkers for pathological invasion in lung adenocarcinoma

Cho¹, HH; Lee, G; Lee, HY; Park, H

PLoS One 2020 10.1371/journal.pone.0231227

Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles

Yoon¹, HJ; Kang, J; Park, H; Sohn, I; Lee, SH; Lee, HY

KOREAN J RADIOL 2020 10.3348/kjr.2019.0630

Radiomics in Lung Cancer from Basic to Advanced: Current Status and Future Directions

Lee¹, G; Park, H; Bak, SH; Lee, HY

RESP RES 2020 10.1186/s12931-019-1254-0

Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer

Shin¹, S; Choi, YS; Jung, JJ; Im, Y; Shin, SH; Kang, D; Cho, JH; Kim, HK; Kim, J; Zo, JI; Shim, YM; Park, K; Ahn, MJ; Ahn, YC; Lee, G; Cho, J; Lee, HY; Park, HY

Sci Rep. 2019 Jun 19;9(1):8730. doi: 10.1038/s41598-019-45117-y.

Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer.

Bak SH¹, Park H, Sohn I, Lee SH, Ahn MJ, Lee HY(corresponding author).

Int J Cancer. 2019 Feb 26.

Improved Treatment Outcome of Pembrolizumab in Patients with Non-small Cell Lung Cancer and Chronic Obstructive Pulmonary Disease.

Shin SH1¹, Park HY1, Im Y1, Jung HA2, Sun JM2, Ahn JS2, Ahn MJ2, Park K2, Lee HY3, Lee SH2,4.

PLos One. 2019 Apr 18;14(4):e0215303.

Correction: Predicting clinical outcome with phenotypic clusters using quantitative CT fibrosis and emphysema features in patients with idiopathic pulmonary fibrosis.

Bak SH¹, Park HY, Nam JH, Lee HY, Lee JH, Sohn I, Chung MP.

Radiology. 2019;290:805-806.

Does Spectral CT Provide Added Diagnostic Value for Defining Malignant Pleural Disease?

Lee KS¹, Lee HY.

Eur Radiol. 2019 Jan 29(1):468-475.

Clustering approach to identify intratumour heterogeneity combining FDG PET and diffusion-weighted MRI in lung adenocarcinoma.

Kim J¹, Ryu SY, Lee SH, Lee HY, Park H.

J Thorac Imag. 2019 Mar;34(2):103-115.

Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer: Improvements using Radiomics.

Lee G¹, Bak SH, Lee HY(corresponding author), Choi JY, Park H, Ohno Y, Nishino M, Edwin J.R. van Beek, Lee KS

Korean J Radiol. 2019 May;20(5):854-861.

Quantitative Thoracic Magnetic Resonance Criteria for the Differentiation of Cysts from Solid Masses in the Anterior Mediastinum.

Hwang EJ¹, Paek M, Yoon SH, Kim J, Lee HY, Goo JM, Kim H, Kim H, Ackman JB.

J Thorac Oncol. 2019 Jun 10. pii: S1556-0864(19)30454-X. doi: 10.1016/j.jtho.2019.05.033. [Epub ahead of print]

Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor

Kim Y¹, Kim CH, Lee HY(co-first author), Lee SH, Kim SH, Lee S, Cha H, Hong S, Kim K, Seo SW, Sun JM, Ahn MJ, Ahn JS, Park K.

Expert Rev Respir Med 2019 10.1080/17476348.2020.1697853

Management of incidental pulmonary nodules: current strategies and future perspectives

Kim¹, TJ; Kim, CH; Lee, HY; Chung, MJ; Shin, SH; Lee, KJ; Lee, KS

INT J CANCER 2019 10.1002/ijc.32235

Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease

Shin¹, SH; Park, HY; Im, Y; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, HY; Lee, SH

J THORAC ONCOL 2019 10.1016/j.jtho.2019.05.033

Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor

Kim¹, Y; Kim, CH; Lee, HY; Lee, SH; Kim, HS; Lee, S; Cha, H; Hong, S; Kim, K; Seo, SW; Sun, JM; Ahn, MJ; Ahn, JS; Park, K

RESP RES 2019 10.1186/s12931-019-1087-x

Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer

Im¹, Y; Park, HY; Shin, S; Shin, SH; Lee, H; Ahn, JH; Sohn, I; Cho, JH; Kim, HK; Zo, JI; Shim, YM; Lee, HY; Kim, J

Cancer Imaging 2019 10.1186/s40644-019-0239-z

Clinical impact of variability on CT radiomics and suggestions for suitable feature selection: a focus on lung cancer

Lee¹, SH; Cho, HH; Lee, HY; Park, H

SCI REP-UK 2019 10.1038/s41598-019-45117-y

Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer

Bak¹, SH; Park, H; Sohn, I; Lee, SH; Ahn, MJ; Lee, HY

KOREAN J RADIOL 2019 10.3348/kjr.2018.0699

Quantitative Thoracic Magnetic Resonance Criteria for the Differentiation of Cysts from Solid Masses in the Anterior Mediastinum

Hwang¹, EJ; Paek, M; Yoon, SH; Kim, J; Lee, HY; Goo, JM; Kim, H; Kim, H; Ackman, JB

PLoS One 2019 10.1371/journal.pone.0215303

Predicting clinical outcome with phenotypic clusters using quantitative CT fibrosis and emphysema features in patients with idiopathic pulmonary fibrosis

Bak¹, SH; Park, HY; Nam, JH; Lee, HY; Lee, JH; Sohn, I; Chung, MP

J THORAC IMAG 2019 10.1097/RTI.0000000000000390

Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer Improvements Using Radiomics

Lee¹, G; Bak, SH; Lee, HY; Choi, JY; Park, H; Lee, SH; Ohno, Y; Nishino, M; van Beek, EJR; Lee, KS

RADIOLOGY 2019 10.1148/radiol.2018182768

Does Spectral CT Provide Added Diagnostic Value for Defining Malignant Pleural Disease?

Lee¹, KS; Lee, HY

EUR RADIOL 2019 10.1007/s00330-018-5590-0

Clustering approach to identify intratumour heterogeneity combining FDG PET and diffusion-weighted MRI in lung adenocarcinoma

Kim¹, J; Ryu, SY; Lee, SH; Lee, HY; Park, H

PLoS One. 2018 Jul 31;13(7):e0201242.

Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults.

Yang B¹, Jhun BW, Shin SH, Jeong BH, Um SW, Zo JI, Lee HY, Sohn I, Kim H, Kwon OJ, Lee K

J Thorac Oncol 2018 Aug;13(8):1106-1112.

Transient asymptomatic pulmonary opacities during osimertinib treatment and its clinical implication.

Lee H¹, Lee HY(co-first author), Sun JM, Lee SH, Kim Y, Park SE, Ahn JS, Park K, Ahn MJ

J Biopharm stat. 2018;28(5):927-938.

Statistical Methods for Conditional Survival Analysis.

Jung SH¹, Lee HY, Chow SC.

AJR Am J Roentgenol. 2018 Jun;210(6):1216-1225.

Morphologic Characterization of Pulmonary Nodules With Ultrashort TE MRI at 3T.

Wielp?tz MO¹, Lee HY, Koyama H, Yoshikawa T, Seki S, Kishida Y, Sakai Y, Kauczor HU, Sugimura K, Ohno Y.

Oncologist 2018 Jul;23(7):806-813.

Comprehensive CT Radiomic s Analysis of Lung Adenocarcinoma for Prognostication.

Lee G¹, Park H, Sohn I, See SH, Song SH, Kim H, Lee KS, Shim YM, Lee HY(corresponding author).

J Pathol Transl Med. 2018 May;52(3):148-156.

Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01).

Ku BM¹, Heo MH, Kim JH, Cho BC, Cho EK, Min YJ, Lee KH, Sun JM, Lee SH, Ahn JS, Park K, Kim TJ, Lee HY, Kim H, Lee KJ, Ahn MJ

Nucl Med Mol Imaging 2018 Apr;52(2):91-98.

CT Radiomics in Thoracic Oncology: Technique and Clinical Applications.

Lee G¹, Bak SH, Lee HY(corresponding author).

Sci Rep 2018 Jun 12;8(1):8968.

Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach

Lee SW¹, Park H, Lee HY(corresponding author), Sohn I, Lee SH, Kang J, Sun JM, Ahn MJ.

Sci Rep 2018 Feb 19;8(1):3284.

Imaging genotyping of functional signaling pathways in lung squamous cell lung carcinoma using a radiomics approach.

Bak SH¹, Park H, Lee HY(corresponding author), Kim Y, Kim HL, Jung SH, Kim H, Kim J, Park K.

Sci Rep. 2018 May 16;8(1):7691.

Genomic alterations of ground-glass nodular lung adenocarcinoma

Lee H¹, Joung JG, Shin HT, Kim DH, Kim Y, Kim H, Kwon OJ, Shim YM, Lee HY, Lee KS, Choi YL, Park WY, Hayes DN, Um SW.

AJR Am J Roentgenol. 2018 Nov;211(5):1026-1034.

Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.

Kim J¹, Choi SJ, Lee SH, Lee HY, Park H

AM J ROENTGENOL 2018 10.2214/AJR.18.19507

Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics

Kim¹, J; Choi, SJ; Lee, SH; Lee, HY; Park, H

J BIOPHARM STAT 2018 10.1080/10543406.2017.1405012

Statistical Methods for Conditional Survival Analysis

Jung¹, SH; Lee, HY; Chow, SC

J THORAC ONCOL 2018 10.1016/j.jtho.2018.04.038

Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication

Lee¹, H; Lee, HY; Sun, JM; Lee, SN; Kim, Y; Park, SE; Ahn, JS; Park, K; Ahn, MJ

PLoS One 2018 10.1371/journal.pone.0201242

Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults

Yang¹, B; Jhun, BW; Shin, SH; Jeong, BH; Um, SW; Zo, JI; Lee, HY; Sohn, I; Kim, H; Kwon, OJ; Lee, K

ONCOLOGIST 2018 10.1634/theoncologist.2017-0538

Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication

Lee¹, G; Park, H; Sohn, I; Lee, SH; Song, SH; Kim, H; Lee, KS; Shim, YM; Lee, HY

AM J ROENTGENOL 2018 10.2214/AJR.17.18961

Morphologic Characterization of Pulmonary Nodules With Ultrashort TE MRI at 3T

Wielputz¹, MO; Lee, HY; Koyama, H; Yoshikawa, T; Seki, S; Kishida, Y; Sakai, Y; Kauczor, HU; Sugimura, K; Ohno, Y

SCI REP-UK 2018 10.1038/s41598-018-27273-9

Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach

Lee¹, SW; Park, H; Lee, HY; Sohn, I; Lee, SH; Kang, J; Sun, JM; Ahn, MJ

SCI REP-UK 2018 10.1038/s41598-018-25800-2

Genomic alterations of ground-glass nodular lung adenocarcinoma

Lee¹, H; Joung, JG; Shin, HT; Kim, DH; Kim, Y; Kim, H; Kwon, OJ; Shim, YM; Lee, HY; Lee, KS; Choi, YL; Park, WY; Hayes, DN; Um, SW

SCI REP-UK 2018 10.1038/s41598-018-21706-1

Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach

Bak¹, SH; Park, H; Lee, HY; Kim, Y; Kim, HL; Jung, SH; Kim, H; Kim, J; Park, K

Journal of thoracic disease 2018 10.21037/jtd.2017.12.38

Prognostic significance of histologic classification and tumor disappearance rate by computed tomography in lung cancer

Kim¹, D; Kim, HK; Kim, SH; Lee, HY; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Shim, YM

Int J Chron Obstruct Pulmon Dis 2017 10.2147/COPD.S146899

Overlaps and uncertainties of smoking-related idiopathic interstitial pneumonias

Bak¹, SH; Lee, HY

J Thorac Oncol. 2017 Apr;12(4):624-632. doi: 10.1016/j.jtho.2016.11.2230. Epub 2016 Dec 5.

Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma

Song SH1¹, Park H2, Lee G3, Lee HY4, Sohn I5, Kim HS5, Lee SH6, Jeong JY7, Kim J8, Lee KS1, Shim YM8.

Eur J Radiol. 2017 Jan;86:297-307. doi: 10.1016/j.ejrad.2016.09.005. Epub 2016 Sep 10.

Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: State of the art

Lee G1¹, Lee HY2, Park H3, Schiebler ML4, van Beek EJR5, Ohno Y6, Seo JB7, Leung A8.

Eur Radiol. 2016 May;26(5):1368-77. doi: 10.1007/s00330-015-3946-2. Epub 2015 Aug 9.

Perfusion- and pattern-based quantitative CT indexes using contrast-enhanced dual-energy computed tomography in diffuse interstitial lung disease: relationships with physiologic impairment and prediction of prognosis

Moon JW1¹, Bae JP2, Lee HY3, Kim N4, Chung MP5, Park HY5, Chang Y2, Seo JB2, Lee KS6.

Cancer Imaging. 2016 Mar 16;16:5. doi: 10.1186/s40644-016-0063-7.

Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study

Lee JH1¹, Lee HY2, Ahn MJ3, Park K3, Ahn JS3, Sun JM3, Lee KS1.

Expert Rev Respir Med. 2016;10(3):261-78. doi: 10.1586/17476348.2016.1141053. Epub 2016 Feb 2.

Improvement in imaging diagnosis technique and modalities for solitary pulmonary nodules: from ground-glass opacity nodules to part-solid and solid nodules

Cha MJ1¹, Lee KS1, Kim HS1, Lee SW1, Jeong CJ1, Kim EY1, Lee HY1.

Chest. 2016 Jan;149(1):180-91. doi: 10.1378/chest.15-0034. Epub 2016 Jan 6.

Quantitative CT Scanning Analysis of Pure Ground-Glass Opacity Nodules Predicts Further CT Scanning Change

Bak SH1¹, Lee HY2, Kim JH1, Um SW3, Kwon OJ3, Han J4, Kim HK5, Kim J5, Lee KS1.

J Thorac Cardiovasc Surg. 2016 Jan;151(1):280-1. doi: 10.1016/j.jtcvs.2015.10.022.

IS PREOPERATIVE POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY A USEFUL DIAGNOSTIC OR STAGING TOOL FOR PURE GROUND GLASS OPACITY NODULAR ADENOCARDINOMAS Reply

Cho H1¹, Lee HY2.

Eur Radiol. 2016 Jan;26(1):43-54. doi: 10.1007/s00330-015-3816-y. Epub 2015 May 17.

y Quantitative CT analysis of pulmonary ground-glass opacity nodules for distinguishing invasive adenocarcinoma from non-invasive or minimally invasive adenocarcinoma: the added value of using iodine mapping

Son JY1¹, Lee HY2, Kim JH1, Han J3, Jeong JY3,4, Lee KS1, Kwon OJ5, Shim YM6.

Diagn Interv Radiol. 2016 Sep-Oct;22(5):407-21. doi: 10.5152/dir.2016.16123.

Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications

Ohno Y1¹, Koyama H, Lee HY, Miura S, Yoshikawa T, Sugimura K.

J Thorac Oncol. 2016 Jul;11(7):1064-73. doi: 10.1016/j.jtho.2016.03.011. Epub 2016 Mar 22.

Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas

Lee HY1¹, Cha MJ1, Lee KS2, Lee HY1, Kwon OJ3, Choi JY4, Kim HK5, Choi YS5, Kim J5, Shim YM5.

Radiology. 2016 Jul;280(1):324-6. doi: 10.1148/radiol.2016152476.

Management of CT Screening-detected Persistent Nonsolid Pulmonary Nodules: An Asian Perspective

Yi CA1¹, Lee HY1, Kim TJ1, Lee KS1.

J Thorac Imaging. 2016 Jul;31(4):215-27. doi: 10.1097/RTI.0000000000000210.

Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging

Ohno Y1¹, Koyama H, Lee HY, Yoshikawa T, Sugimura K.

Eur Radiol. 2016 Jun;26(6):1538-46. doi: 10.1007/s00330-015-4029-0. Epub 2015 Oct 11.

Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma

Song SH1¹, Ahn JH2, Lee HY3, Lee G4, Choi JY5, Kang J6, Kim EY1, Han J7, Kwon OJ8, Lee KS1, Kim HK9, Choi YS9, Kim J9, Shim YM9.

CHEST, JUN 2016, 149(6):1587-1588, DOI: 10.1016/j.chest.2016.04.005

Quantitative CT Scanning Analysis of Pure Ground-Glass Opacity Nodules Predicts Further CT Change Response

Bak SH¹, Lee HY

Diagn Interv Radiol. 2016 May-Jun;22(3):231-40. doi: 10.5152/dir.2015.15171.

Perfusion parameters as potential imaging biomarkers for the early prediction of radiotherapy response in a rat tumor model

Lee HY1¹, Kim N, Goo JM, Chie EK, Song HJ.

J Thorac Cardiovasc Surg. 2015 Sep;150(3):514-20. doi: 10.1016/j.jtcvs.2015.06.024. Epub 2015 Jun 18.

Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary

Cho H1¹, Lee HY2, Kim J3, Kim HK3, Choi JY4, Um SW5, Lee KS1.

KOREAN JOURNAL OF RADIOLOGY, SEP-OCT 2015, 16(5):1166-1170, 10.3348/kjr.2015.16.5.1166

Primary Pulmonary Low-Grade Angiosarcoma Characterized by Mismatch between F-18-FDG PET and Dynamic Contrast-Enhanced CT

Kim EY¹, Lee HY, Han J, Choi JY,

J Thorac Oncol. 2015 Dec;10(12):1785-94. doi: 10.1097/JTO.0000000000000689.

Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma

Lee HY1¹, Lee SW, Lee KS, Jeong JY, Choi JY, Kwon OJ, Song SH, Kim EY, Kim J, Shim YM.

J Thorac Cardiovasc Surg. 2015 Sep;150(3):514-20. doi: 10.1016/j.jtcvs.2015.06.024. Epub 2015 Jun 18.

Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary

Cho H1¹, Lee HY2, Kim J3, Kim HK3, Choi JY4, Um SW5, Lee KS1.

Korean J Radiol. 2015 Jul-Aug;16(4):942-6. doi: 10.3348/kjr.2015.16.4.942. Epub 2015 Jul 1.

Lung Infarction due to Pulmonary Vein Stenosis after Ablation Therapy for Atrial Fibrillation Misdiagnosed as Organizing Pneumonia: Sequential Changes on CT in Two Cases

Kwon MR1¹, Lee HY1, Cho JH2, Um SW3.

Chest. 2015 May;147(5):1299-306. doi: 10.1378/chest.14-0717.

Change of Junctions Between Stations 10 and 4 in the New International Association for the Study of Lung Cancer Lymph Node Map A Validation Study from a Single, Tertiary Referral Hospital Experience

Lee S¹, Lee HY, Lee KS, Yie M, Zo J, Shim YM, Han J, Ahn JH.

Am J Surg Pathol. 2015 May;39(5):660-6. doi: 10.1097/PAS.0000000000000399.

Clinical Impact of Minimal Micropapillary Pattern in Invasive Lung Adenocarcinoma Prognostic Significance and Survival Outcomes

Lee G1¹, Lee HY, Jeong JY, Han J, Cha MJ, Lee KS, Kim J, Shim YM.

Clin Lung Cancer. 2015 May;16(3):228-36. doi: 10.1016/j.cllc.2014.11.002. Epub 2014 Nov 18.

Survival Outcome Assessed According to Tumor Burden and Progression Patterns in Patients With Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Undergoing Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Cha YK1¹, Lee HY2, Ahn MJ3, Choi YL4, Lee JH1, Park K3, Lee KS1.

Ann Thorac Med.?2015 Apr-Jun;10(2):105-11. doi: 10.4103/1817-1737.151441.

Chronic obstructive pulmonary disease severity is associated with severe pneumonia

Eom JS1¹,?Song WJ2,?Yoo H2,?Jeong BH2,?Lee HY3,?Koh WJ2,?Jeon K2,?Park HY2.

Cancer Chemother Pharmacol.?2015 Jan;75(1):77-85. doi: 10.1007/s00280-014-2619-1. Epub 2014 Nov 6.

Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery

Lim HJ1¹,?Lee HY,?Lee KS,?Han J,?Kwon OJ,?Park K,?Ahn YC,?Kim BT,?Shim YM.

Clin Nucl Med. 2015 Jan;40(1):e34-9. doi: 10.1097/RLU.0000000000000581.

Role of Imaging Biomarkers in Predicting Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma

Jeong CJ1¹, Lee HY, Han J, Jeong JY, Lee KS, Choi YL, Choi JY.

World J Gastroenterol. 2014 May 28;20(20):6133-45. doi: 10.3748/wjg.v20.i20.6133.

Pulmonary metastasectomy for colorectal cancer: How many nodules, how many times

Kim HK1¹, Cho JH1, Lee HY1, Lee J1, Kim J1.

Eur Radiol. 2014 Mar;24(3):677-84. doi: 10.1007/s00330-013-3054-0. Epub 2013 Nov 1.

Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT

Shin KE1¹, Yi CA, Kim TS, Lee HY, Choi YS, Kim HK, Kim J.

Thorac Cardiovasc Surg. 2014 Oct;62(7):616-23. doi: 10.1055/s-0033-1363767. Epub 2014 Apr 20.

Approach to Metastasis-Suspected Nodule Accompanying Operable Non-Small Cell Lung Cancer

Shin S1¹, Park JS2, Kim HK1, Choi YS1, Shim YM1, Lee HY3, Kim J1.

Cancer Res Treat.?2014 Oct;46(4):393-402. doi: 10.4143/crt.2013.132. Epub 2014 Jul 18.

Ultra-Low-Dose Chest CT in Patients with Neutropenic Fever and Hematologic Malignancy: Image Quality and Its Diagnostic Performance

Kim HJ1¹,?Park SY2,?Lee HY1,?Lee KS1,?Shin KE1,?Moon JW1.

Korean J Radiol.?2014 Sep-Oct;15(5):646-50. doi: 10.3348/kjr.2014.15.5.646. Epub 2014 Sep 12.

Synchronous Triple Primary Lung Cancers: A Case Report

Yoon HJ1¹,?Lee HY1,?Han J2,?Choi YL2.

PLoS One.?2014 Sep 9;9(9):e107476. doi: 10.1371/journal.pone.0107476. eCollection 2014.

The Value of CT for Disease Detection and Prognosis Determination in Combined Pulmonary Fibrosis and Emphysema (CPFE)

Choi SH1¹,?Lee HY1,?Lee KS1,?Chung MP2,?Kwon OJ2,?Han J3,?Kim N4,?Seo JB4.

J Urol. 2014 Sep;192(3):940-6. doi: 10.1016/j.juro.2014.03.097. Epub 2014 Apr 1.

Prognostic Significance of Biallelic Loss of PTEN in Clear Cell Renal Cell Carcinoma

Lee HJ1¹, Lee HY2, Lee JH3, Lee H4, Kang G5, Song JS1, Kang J6, Kim JH7.

Quantitative CT Analysis of Pulmonary Ground-Glass Opacity Nodules for the Distinction of Invasive Adenocarcinoma from Pre-Invasive or Minimally Invasive Adenocarcinoma

Reliability of small biopsy or cytology for the diagnosis of pulmonary mucinous adenocarcinoma

AJR Am J Roentgenol.?2014 Mar;202(3):W224-33. doi: 10.2214/AJR.13.11819.

Pure Ground-Glass Opacity Neoplastic Lung Nodules: Histopathology, Imaging, and Management

Lee HY1¹,?Choi YL,?Lee KS,?Han J,?Zo JI,?Shim YM,?Moon JW.

J Thorac Cardiovasc Surg.?2014 Mar;147(3):921-928.e2. doi: 10.1016/j.jtcvs.2013.09.045. Epub 2013 Nov 4.

Micropapillary and solid subtypes of invasive lung adenocarcinoma: Clinical predictors of histopathology and outcome

Cha MJ1¹,?Lee HY2,?Lee KS1,?Jeong JY3,?Han J3,?Shim YM4,?Hwang HS1.

Anticancer Res. 2014 Feb;34(2):707-14.

Assessment of Intratumoral Heterogeneity of Oncogenic Driver Mutations in Surgically-resected Lung Adenocarcinoma: Implications of Percutaneous Biopsy-based Molecular Assay for Target-directed Therapy

Kim HK1¹, Lee HY, Choi YL, Choi SJ, Choi H, Lee J, Han J, Ahn MJ, Lee KS, Kim J.

PLoS One.?2014 Feb 26;9(2):e88598. doi: 10.1371/journal.pone.0088598. eCollection 2014.

Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy

Chong Y1¹,?Kim JH1,?Lee HY1,?Ahn YC2,?Lee KS1,?Ahn MJ3,?Kim J4,?Shim YM4,?Han J5,?Choi YL5.

Anticancer Res.?2013 Nov;33(11):5127-33.

High-throughput Molecular Genotyping for Small Biopsy Samples in Advanced Non-small Cell Lung Cancer Patients

Maeng CH1¹,?Lee HY,?Kim YW,?Choi MK,?Hong JY,?Jung HA,?Lee KS,?Kim H,?Kwon OJ,?Sun JM,?Ahn JS,?Park K,?Um SW,?Ahn MJ.

Clin Rheumatol.?2013 Oct;32(10):1459-65. doi: 10.1007/s10067-013-2304-5. Epub 2013 Jun 2.

Imaging manifestations of autoimmune disease-associated lymphoproliferative disorders of the lung

Lee G1¹,?Lee HY,?Lee KS,?Lee KJ,?Cha HS,?Han J,?Chung MP.

J Magn Reson?Imaging.?2013 Oct;38(4):905-13. doi: 10.1002/jmri.24080. Epub 2013 Mar 21.

Histopathology of Lung Adenocarcinoma Based on New IASLC/ATS/ERS Classification: Prognostic Stratification With Functional and Metabolic Imaging Biomarkers

Lee HY1¹,?Jeong JY,?Lee KS,?Yi CA,?Kim BT,?Kang H,?Kwon OJ,?Shim YM,?Han J.

Korean J Radiol.?2013 Jul-Aug;14(4):692-6. doi: 10.3348/kjr.2013.14.4.692. Epub 2013 Jul 17.

Uncommon of the Uncommon: Malignant Perivascular Epithelioid Cell Tumor of the Lung

Lim HJ1¹,?Lee HY,?Han J,?Choi YS,?Lee KS.

Korean J Radiol.?2013 Mar-Apr;14(2):384-8. doi: 10.3348/kjr.2013.14.2.384. Epub 2013 Feb 22.

Pulmonary Mucinous Cystadenocarcinoma: Report a Case and Review of CT Findings

Choi YA1¹,?Lee HY,?Han J,?Choi JY,?Kim J,?Kwon OJ,?Lee KS.

Radiology. 2013 Feb;266(2):626-35. doi: 10.1148/radiol.12120385. Epub 2012 Dec 6.

Chronic Obstructive Pulmonary Disease: Lobe-based Visual Assessment of Volumetric CT by Using Standard Images-Comparison with Quantitative CT and Pulmonary Function Test in the COPDGene Study

Kim SS1¹, Seo JB, Lee HY, Nevrekar DV, Forssen AV, Crapo JD, Schroeder JD, Lynch DA.

Radiology.?2012 Dec;265(3):939-48. doi: 10.1148/radiol.12112613. Epub 2012 Aug 28.

Repeat Biopsy for Mutational Analysis of Non-Small Cell Lung Cancers Resistant to Previous Chemotherapy: Adequacy and Complications

Yoon HJ1¹,?Lee HY,?Lee KS,?Choi YL,?Ahn MJ,?Park K,?Ahn JS,?Sun JM,?Kim J,?Kim TS,?Chung MJ,?Yi CA.

Korean J Radiol.?2012 Nov-Dec;13(6):702-10. doi: 10.3348/kjr.2012.13.6.702. Epub 2012 Oct 12.

Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response

Kim YN1¹,?Lee HY,?Lee KS,?Seo JB,?Chung MJ,?Ahn MJ,?Park K,?Kim TS,?Yi CA.

AJR Am J Roentgenol.?2012 Nov;199(5):982-9. doi: 10.2214/AJR.11.8192.

High-Resolution CT Findings in Fibrotic Idiopathic Interstitial Pneumonias With Little Honeycombing: Serial Changes and Prognostic Implications

Lee HY1¹,?Lee KS,?Jeong YJ,?Hwang JH,?Kim HJ,?Chung MP,?Han J.

Radiology.?2012 Sep;264(3):884-93. doi: 10.1148/radiol.12111793. Epub 2012 Jul 24.

Solitary Pulmonary Nodular Lung Adenocarcinoma: Correlation of Histopathologic Scoring and Patient Survival with Imaging Biomarkers

Lee HY1¹,?Jeong JY,?Lee KS,?Kim HJ,?Han J,?Kim BT,?Kim J,?Shim YM,?Kim JH,?Song I.

J PEDIATR SURG/ 2012;47:1629

Computed Tomography-Guided Localization of Lung Nodules: Dealing with Initial Mislocalization

Jung Won Moon¹, Ho Yun Lee, Yong Soo Choi, Kyung Soo Lee

Korean J Radiol.?2012 Jul-Aug;13(4):371-90. doi: 10.3348/kjr.2012.13.4.371. Epub 2012 Jun 18.

Imaging-Based Tumor Treatment Response Evaluation: Review of Conventional, New, and Emerging Concepts

Kang H1¹,?Lee HY,?Lee KS,?Kim JH.

Acad Radiol.?2012 Apr;19(4):440-5. doi: 10.1016/j.acra.2011.12.010. Epub 2012 Jan 23.

Baseline SUVmax at PET-CT in Stage IIIA Non-small-cell Lung Cancer Patients Undergoing Surgery after Neoadjuvant Therapy: Prognostic Implication Focused on Histopathologic Subtypes

Lee HY1¹,?Lee KS,?Park J,?Han J,?Kim BT,?Kwon OJ,?Ahn YC,?Ahn MJ,?Park K,?Kim J,?Shim YM.

J Thorac Cardiovasc Surg.?2012 Apr;143(4):809-14. doi: 10.1016/j.jtcvs.2011.10.038. Epub 2011 Nov 20.

Factors determining successful computed tomography-guided localization of lung nodules

Seo JM1¹,?Lee HY,?Kim HK,?Choi YS,?Kim J,?Shim YM,?Lee KS.

Intern Med.?2011;50(24):3027-9. Epub 2011 Dec 15.

Tree-In-Bud Sign as a Manifestation of Localized Pulmonary Lymphatic Metastasis from a Pancreas Cancer

Moon JW1¹,?Lee HY,?Han J,?Lee KS.

Cancer?Chemother Pharmacol.?2011 Nov;68(5):1099-109. doi: 10.1007/s00280-011-1737-2. Epub 2011 Sep 13.

Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight

Min JH1¹,?Lee HY,?Lim H,?Ahn MJ,?Park K,?Chung MP,?Lee KS.

Lung?Cancer.?2011 Jul;73(1):63-9. doi: 10.1016/j.lungcan.2010.10.019. Epub 2010 Nov 18.

New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy

Lee HY1¹,?Lee KS,?Ahn MJ,?Hwang HS,?Lee JW,?Park K,?Ahn JS,?Kim TS,?Yi CA,?Chung MJ.

J Thorac?Imaging.?2011 May;26(2):106-18. doi: 10.1097/RTI.0b013e3181fbaa64.

Ground-glass Opacity Nodules Histopathology, Imaging Evaluation, and Clinical Implications

Lee HY1¹,?Lee KS.

Korean J Radiol.?2010 Nov-Dec;11(6):618-26. doi: 10.3348/kjr.2010.11.6.618. Epub 2010 Oct 29.

Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria

Lee HY1¹,?Lee KS,?Hwang HS,?Lee JW,?Ahn MJ,?Park K,?Kim TS,?Yi CA,?Chung MJ.

Ann Surg Oncol.?2010 Oct;17(10):2787-94. doi: 10.1245/s10434-010-1107-z. Epub 2010 May 12.

Volume-Based Parameter of F-18-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications

Lee HY1¹,?Hyun SH,?Lee KS,?Kim BT,?Kim J,?Shim YM,?Ahn MJ,?Kim TS,?Yi CA,?Chung MJ.

Lung?Cancer.?2010 Jul;69(1):123-6. doi:?10.1016/j.lungcan.2010.04.022. Epub 2010 May 16.

Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: An observation for more than 10 years

Min JH1¹,?Lee HY,?Lee KS,?Han J,?Park K,?Ahn MJ,?Lee SJ.

J Korean Med Sci.?2009 Dec;24(6):1132-8. doi: 10.3346/jkms.2009.24.6.1132. Epub 2009 Nov 9.

Diagnostic Efficacy of PET/CT Plus Brain MR Imaging for Detection of Extrathoracic Metastases in Patients with Lung Adenocarcinoma

Lee HY1¹,?Lee KS,?Kim BT,?Cho YS,?Lee EJ,?Yi CA,?Chung MJ,?Kim TS,?Kwon OJ,?Kim H.

Lung Cancer.?2009 Aug;65(2):170-5. doi: 10.1016/j.lungcan.2008.11.009. Epub 2008 Dec 27.

Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons

Lee HY1¹,?Lee KS,?Han J,?Kim BT,?Cho YS,?Shim YM,?Kim J.

Korean J Radiol.?2009 May-Jun;10(3):244-51. doi: 10.3348/kjr.2009.10.3.244. Epub 2009 Apr 22.

Classification of Focal Prostatic Lesions on Transrectal Ultrasound (TRUS) and the Accuracy of TRUS to Diagnose Prostate Cancer

Lee HY1¹,?Lee HJ,?Byun SS,?Lee SE,?Hong SK,?Kim SH.